Cellectar stock climbs 8% on results for CNS malignancy therapy (NASDAQ:CLRB)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.